Vicor CapEx increased by 123.5% to $12.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 172.2%, from $4.55M to $12.39M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -19.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.52M | $15.16M | $16.82M | $22.68M | $14.20M | $14.40M | $12.69M | $10.09M | $8.54M | $7.66M | $7.16M | $7.27M | $6.14M | $8.46M | $1.74M | $4.55M | $6.20M | $4.02M | $5.54M | $12.39M |
| QoQ Change | — | +132.6% | +10.9% | +34.9% | -37.4% | +1.5% | -11.9% | -20.5% | -15.4% | -10.3% | -6.5% | +1.5% | -15.5% | +37.7% | -79.5% | +162.1% | +36.4% | -35.2% | +37.9% | +123.5% |
| YoY Change | — | — | — | — | +117.8% | -5.0% | -24.6% | -55.5% | -39.9% | -46.8% | -43.5% | -27.9% | -28.1% | +10.3% | -75.8% | -37.4% | +1.0% | -52.4% | +219.3% | +172.2% |